Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
Beyond Standard Radiotherapy: an AI-Driven Framework for Personalized Radiotherapy with a Four-Step Classification in
Yongxin Guo1,2, Eric O Aboagye1, Dorothy M Gujral3
1Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, W12 0NN, United Kingdom.
Purpose Of Review:
Radiotherapy (RT) is a mainstay treatment strategy for patients with radically treatable head and neck cancer (HNC). Efforts to personalize RT have spanned decades, yielding variable results across different treatment stages. The purpose of this review was to assess the potential of AI-driven models to bridge personalized radiotherapy strategies.
Recent Findings:
Radiomics, an emerging imaging analytics approach, provides significant quantitative features that can predict survival outcomes, treatment responses, and radiation-induced toxicity. Radiomics-based models in the studies demonstrate promising predictive efficacy with a high C-index or area under the curve (AUC) exceeding 0.70. AI-driven multimodal and multitemporal imaging models can stratify patients and guide risk-adapted radiotherapy. A four-step AI-driven RT framework may provide a template for future randomized controlled trials, supporting more trustworthy evidence.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers

